miR-186 inhibits cell proliferation in multiple myeloma by repressing Jagged1

被引:42
|
作者
Liu, Zengyan [1 ,2 ]
Zhang, Guoqiang [3 ]
Yu, Wenzheng [2 ]
Gao, Na [2 ]
Peng, Jun [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Hematol, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China
[2] Binzhou Med Univ, Dept Hematol, 661 Second Huanghe St, Binzhou 256603, Peoples R China
[3] Binzhou Med Univ, Dept Thyroid & Breast Surg, 661 Second Huanghe St, Binzhou 256603, Peoples R China
关键词
miR-186; Jagged1; Multiple myeloma; Proliferation; LUNG-CANCER CELLS; DISEASE PROGRESSION; DOWN-REGULATION; EXPRESSION; MICRORNA; SURVIVAL; GROWTH; METASTASIS; NOTCH; BIOGENESIS;
D O I
10.1016/j.bbrc.2015.11.136
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) are small, noncoding ribonucleic acids that regulate gene expression by targeting mRNAs for translational repression and degradation. Accumulating experimental evidence supports a causal role of miRNAs in hematology tumorigenesis. However, the specific functions of miRNAs in the pathogenesis of multiple myeloma (MM) remain to be established. In this study, we demonstrated that miR-186 is commonly downregulated in MM cell lines and patient MM cells. Ectopic expression of miR-186 significantly inhibited cell growth, both in vitro and in vivo, and induced cell cycle G0/G1 arrest. Furthermore, miR-186 induced downregulation of Jagged1 protein expression by directly targeting its 3'-untranslated region (3'-UTR). Conversely, overexpression of Jagged1 rescued cells from miR-186-induced growth inhibition. Our collective results clearly indicate that miR-186 functions as a tumor suppressor in MM, supporting its potential as a therapeutic target for the disease. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:692 / 697
页数:6
相关论文
共 50 条
  • [41] miR-186 Inhibits Liver Cancer Stem Cells Expansion via Targeting PTPN11
    Yao, Haochen
    Yang, Ziting
    Lou, Yan
    Huang, Juanjuan
    Yang, Pinghua
    Jiang, Weiqi
    Chen, Shuai
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms
    Neviani, Paolo
    Wise, Petra M.
    Murtadha, Mariam
    Liu, Cathy W.
    Wu, Chun-Hua
    Jong, Ambrose Y.
    Seeger, Robert C.
    Fabbri, Muller
    CANCER RESEARCH, 2019, 79 (06) : 1151 - 1164
  • [43] miR-186 and 326 Predict the Prognosis of Pancreatic Ductal Adenocarcinoma and Affect the Proliferation and Migration of Cancer Cells
    Zhang, Zheng-liang
    Bai, Zheng-hai
    Wang, Xiao-bo
    Bai, Ling
    Miao, Fei
    Pei, Hong-hong
    PLOS ONE, 2015, 10 (03):
  • [44] Hsa-miR-599 inhibits breast cancer progression via BRD4/Jagged1/Notch1 axis
    Liu, Yang
    Liu, Ning
    Xu, Danfeng
    Wu, Baohui
    Wu, Xiaosheng
    Sun, Xia
    Yang, Yi
    Yan, Fengqin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (01) : 523 - 531
  • [45] Long non-coding RNA OIP5-AS1 promotes cell proliferation and aerobic glycolysis in gastric cancer through sponging miR-186
    Huang, Jiaobao
    Hou, Shuangshuang
    Xu, Jian
    Wu, Ju
    Yin, Jiajun
    ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (06) : 1742 - 1751
  • [46] SNHG1/miR-186/FUT8 regulates cell migration and invasion in oral squamous cell carcinoma
    Zhao, Yanxia
    Shi, Jun
    Zhao, Yankun
    Lu, Zhifang
    ORAL DISEASES, 2023, 29 (01) : 105 - 115
  • [47] MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1
    Yao, Kun
    He, Leye
    Gan, Yu
    Zeng, Qing
    Dai, Yingbo
    Tan, Jing
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [48] Circ0038632 modulates MiR-186/DNMT3A axis to promote proliferation and metastasis in osteosarcoma
    Tan, Xinyu
    Zeng, Canjun
    Li, Haomiao
    Tan, Yeru
    Zhu, Hongbo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Bruceine D inhibits hepatocellular carcinoma growth by targeting β-catenin/jagged1 pathways
    Cheng, Ziying
    Yuan, Xing
    Qu, Yi
    Li, Xia
    Wu, Guozhen
    Li, Chenwei
    Zu, Xianpeng
    Yang, Niao
    Ke, Xisong
    Zhou, Juan
    Xie, Ning
    Xu, Xike
    Liu, Shanrong
    Shen, Yunheng
    Li, Huiliang
    Zhang, Weidong
    CANCER LETTERS, 2017, 403 : 195 - 205
  • [50] Inhibition of miR-186 and repression of aggressive prostate cancer phenotype using a metastatic cell model
    Jones, Dominique Z.
    Schmidt, M. Lee
    Hobbing, Katharine R.
    Clark, Geoffrey
    Kidd, LaCreis R.
    CANCER RESEARCH, 2016, 76